Real-life experience with hydroxyurea in sickle cell disease: A multicenter study in a cohort of patients with heterogeneous descent

We conducted the first nation-wide cohort study of sickle cell disease (SCD) in Italy, a Southern European country exposed to intense recent flux migration from endemic areas for SCD. We evaluate the impact of hydroxyurea on a total of 652 pediatric and adult patients from 33 Reference Centers for S...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Blood cells, molecules, & diseases molecules, & diseases, 2018-03, Vol.69, p.82-89
Hauptverfasser: Rigano, Paolo, De Franceschi, Lucia, Sainati, Laura, Piga, Antonio, Piel, Frédéric B., Cappellini, Maria Domenica, Fidone, Carmelo, Masera, Nicoletta, Palazzi, Giovanni, Gianesin, Barbara, Forni, Gian Luca
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:We conducted the first nation-wide cohort study of sickle cell disease (SCD) in Italy, a Southern European country exposed to intense recent flux migration from endemic areas for SCD. We evaluate the impact of hydroxyurea on a total of 652 pediatric and adult patients from 33 Reference Centers for SCD (mean age 24.5±15years, 51.4% males). Hydroxyurea median treatment duration was 7years (range:
ISSN:1079-9796
1096-0961
DOI:10.1016/j.bcmd.2017.08.017